Mystic, CT, United States of America

Maria Rosario

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Maria Rosario

Introduction: Maria Rosario is a pioneering inventor based in Mystic, CT, USA, known for her significant contributions to the field of biomedicine. With a remarkable portfolio of three patents, Maria is making strides in the development of innovative treatments utilizing antibody formulations.

Latest Patents: Maria's latest patents focus on groundbreaking treatments with anti-α4β7 antibodies. The first patent describes antibody formulations that combine an anti-α4β7 antibody, an antioxidant or chelator, and free amino acids. These formulations offer improved stability and reduced aggregate formation, while also providing a safe and effective dosing regimen that ensures therapeutically relevant amounts of the antibody are delivered in vivo. Her second patent presents methods for predicting patient outcomes when treated with anti-α4β7 integrin antibodies, identifying individuals who would respond favorably to this therapy.

Career Highlights: Maria Rosario is currently employed at Takeda Pharmaceutical Company Limited, where she leverages her expertise in antibody therapeutics to develop innovative solutions for patient care. Her work has significantly impacted the pharmaceutical industry, particularly in the development of targeted therapies.

Collaborations: Throughout her career, Maria has collaborated with esteemed colleagues, including Timothy L. Wyant and Brihad Abhyankar. Their synergistic efforts have contributed to advancements in antibody treatments, enhancing the efficacy of therapies for various medical conditions.

Conclusion: Maria Rosario's commitment to innovation in the field of biomedicine exemplifies the vital role that inventors play in advancing healthcare solutions. Her work with anti-α4β7 antibody formulations not only highlights her ingenuity but also promises to improve patient outcomes in the near future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…